1-(ethylthio)-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexan]-5(7H)-one
- CAS No.
- 374101-64-1
- Chemical Name:
- 1-(ethylthio)-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexan]-5(7H)-one
- Synonyms
- NR2F1 agonist 1;1-(ethylthio)-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexan]-5(7H)-one;Spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6(4H),1'-cyclohexan]-5(7H)-one, 1-(ethylthio)-4-(2-phenylethyl)-
- CBNumber:
- CB44147806
- Molecular Formula:
- C28H30N4OS
- Molecular Weight:
- 470.63
- MDL Number:
- MOL File:
- 374101-64-1.mol
- MSDS File:
- SDS
1-(ethylthio)-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexan]-5(7H)-one price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0652472 | NR2F1 agonist 1 99.06% | 374101-64-1 | 5mg | $769 | 2026-06-04 | Buy |
| ChemScene | CS-0652472 | NR2F1 agonist 1 99.06% | 374101-64-1 | 10mg | $1246 | 2026-06-04 | Buy |
| ChemScene | CS-0652472 | NR2F1 agonist 1 99.06% | 374101-64-1 | 25mg | $2492 | 2026-06-04 | Buy |
| ChemScene | CS-0652472 | NR2F1 agonist 1 99.06% | 374101-64-1 | 50mg | $3987 | 2026-06-04 | Buy |
| aablocks | AA02DHRP | NR2F1 agonist 1 >98% | 374101-64-1 | 5mg | $824 | 2026-06-03 | Buy |
1-(ethylthio)-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexan]-5(7H)-one Chemical Properties, Uses, Production
Uses
NR2F1 agonist 1, a nuclear receptor NR2F1 agonist, specifically activates dormancy programs in malignant cells. NR2F1 agonist 1 up-regulates NR2F1 and downstream target genes that regulate dormancy. NR2F1 agonist 1 induces neural crest-like and growth suppression in head and neck squamous cell carcinoma (HNSCC) via NR2F1 activation. NR2F1 agonist 1 inhibits tumor growth in a mouse primary tumor model[1].
in vivo
NR2F1 agonist 1 (0.5 mg/kg/day; i.p.; 3 weeks) inhibits inhibits primary tumor growth and metastatic growth in lungs in mouse models[1].
| Animal Model: | BALB/c nu/nu mice bearing GFP-tagged T-HEp3 PDX cells[1] |
| Dosage: | 0.5 mg/kg/day |
| Administration: | Intraperitoneal injection; injected for 3 weeks or for 1 week followed by DMSO for 2 weeks |
| Result: | Did not induce apoptosis of proliferating primary tumor cells, but exhibited metastasis inhibitory effect against T-HEp3 cells. |
References
[1] Khalil BD, et al. An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy. J Exp Med. 2022 Jan 3;219(1):e20210836. DOI:10.1084/jem.20210836
1-(ethylthio)-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexan]-5(7H)-one Preparation Products And Raw materials
Raw materials
Preparation Products
1-(ethylthio)-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexan]-5(7H)-one Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
| TargetMol Chemicals Inc. | 13564774135 | marketing@targetmol.com | United States | 19950 | 58 |
| Supplier | Advantage |
|---|---|
| TargetMol Chemicals Inc. | 58 |
| TargetMol Chemicals Inc. | 58 |
View Latest Price from 1-(ethylthio)-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexan]-5(7H)-one manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-15 | NR2F1 agonist 1
374101-64-1
|
$1670.00-2800.00 | 10g | TargetMol Chemicals Inc. |
-

- NR2F1 agonist 1
374101-64-1
- $1670.00-2800.00
- TargetMol Chemicals Inc.
374101-64-1 (1-(ethylthio)-4-phenethyl-4H-spiro[benzo[h][1,2,4]triazolo[4,3-a]quinazoline-6,1'-cyclohexan]-5(7H)-one) Related Search:
1of2




